Anika Therapeutics (ANIK) Change in Inventory (2010 - 2026)

Anika Therapeutics (ANIK) has reported Change in Inventory for 17 consecutive years, with $6.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Inventory rose 447.77% year-over-year to $6.0 million in Q2 2026; TTM through Jun 2026 was $13.6 million, a 931.83% increase from a year earlier, with the FY2025 full-year figure at -$30000.0, down 100.32% from the prior year.
• Change in Inventory was $6.0 million for Q2 2026 at Anika Therapeutics, up from $5.4 million in the prior quarter.
• Over five years, Change in Inventory peaked at $6.0 million in Q2 2026 and troughed at -$2.4 million in Q4 2024.
• A 5-year average of $2.2 million and a median of $2.7 million in 2022 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory sank 176.17% in 2024 and soared 1133.84% in 2026, its largest moves.
• Over 5 years, Change in Inventory stood at $2.9 million in 2022, then advanced by 6.77% to $3.1 million in 2023, then slumped by 176.17% to -$2.4 million in 2024, then jumped by 174.4% to $1.8 million in 2025, then surged by 238.0% to $6.0 million in 2026.
• The last three Change in Inventory figures came in at $6.0 million (Q2 2026), $5.4 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.